HF
ATXI

HRT Financial’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

HRT Financial’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-616
Closed -$6K – 3301
2024
Q1 		$6K Buy
616
+279
+83% +$3.31K ﹤0.01% 2105
2023
Q4 		$4K Buy
+337
New +$7.88K ﹤0.01% 2143
2022
Q3 		– Sell
-35
Closed -$10K – 3647
2022
Q2 		$10K Buy
+35
New +$13.5K ﹤0.01% 2685
2021
Q4 		– Sell
-18
Closed -$29K – 4257
2021
Q3 		$29K Sell
18
-4
-18% -$8.27K ﹤0.01% 3114
2021
Q2 		$61K Buy
+22
New +$109K ﹤0.01% 2663

Other funds holding ATXI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's ATXI Position: Q2 2024 in Review

HRT Financial sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q2 2024, closing a stake of 616 shares — an estimated $6K sold.

HRT Financial first reported a position in ATXI in Q2 2021 and held it in 5 quarters. The position peaked at $61K in Q2 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

  • HRT Financial reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 616 Avenue Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $6K.
  • HRT Financial first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • HRT Financial's Avenue Therapeutics, Inc. Common Stock position peaked at $61K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.